|
|||||
|
|
Treatment persistence with adalimumab, etanercept, or infliximab in combination with methotrexate and the effects on health care costs in patients with rheumatoid arthritis |
|
| Authors: | Tang Boxiong Rahman Mirza Waters Heidi C Callegari Peter |
| Affiliation: | Medical Affairs, Centocor Ortho Biotech Services, LLC, Horsham, Pennsylvania 19044, USA. BTang@cntus.jnj.com |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |